<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Emerging Tech &#8211; BizTech Weekly</title>
	<atom:link href="https://biztechweekly.com/emerging-tech/feed/" rel="self" type="application/rss+xml" />
	<link>https://biztechweekly.com</link>
	<description>The latest in business and technology, at your fingertips</description>
	<lastBuildDate>Thu, 15 Oct 2026 20:59:59 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://biztechweekly.com/wp-content/uploads/2022/01/cropped-BizTechWeeklyLogo-WhiteSquare-32x32.png</url>
	<title>Emerging Tech &#8211; BizTech Weekly</title>
	<link>https://biztechweekly.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Seraphim SpaceTech Investment Tracker: Q3 2026 Hits $20.8 Billion, but Launch Capacity Still Looks Tight</title>
		<link>https://biztechweekly.com/seraphim-spacetech-investment-tracker-q3-2026-hits-20-8-billion-but-launch-capacity-still-looks-tight/</link>
		
		<dc:creator><![CDATA[Emily Johnson]]></dc:creator>
		<pubDate>Thu, 15 Oct 2026 20:59:59 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/seraphim-spacetech-investment-tracker-q3-2026-hits-20-8-billion-but-launch-capacity-still-looks-tight/</guid>

					<description><![CDATA[Seraphim reported record private SpaceTech funding of $20.8 billion in Q3 2026, boosted by Blue Origin’s $10 billion financing. Even excluding that deal, capital still reached a record — but the real test is whether companies can turn funding into launch access, delivered hardware and reliable revenue.]]></description>
		
		
		
			</item>
		<item>
		<title>Science Corporation’s First Stargardt PRIMA Implant Is a Milestone, Not Yet a Treatment Result</title>
		<link>https://biztechweekly.com/science-corporations-first-stargardt-prima-implant-is-a-milestone-not-yet-a-treatment-result/</link>
		
		<dc:creator><![CDATA[Sophia Chen]]></dc:creator>
		<pubDate>Wed, 14 Oct 2026 12:28:43 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/science-corporations-first-stargardt-prima-implant-is-a-milestone-not-yet-a-treatment-result/</guid>

					<description><![CDATA[Science says the first Stargardt-disease patient in its PRIMAlia study received a PRIMA retinal implant in May and saw a letter during rehabilitation. The development extends the device into inherited blindness, but a five-person exploratory trial is far too early to show efficacy or commercial readiness.]]></description>
		
		
		
			</item>
		<item>
		<title>IonQ’s Up-to-$1.3 Billion Elisity Deal Tests Whether Quantum Security Can Sell Now</title>
		<link>https://biztechweekly.com/ionqs-up-to-1-3-billion-elisity-deal-tests-whether-quantum-security-can-sell-now/</link>
		
		<dc:creator><![CDATA[Liam Brown]]></dc:creator>
		<pubDate>Tue, 13 Oct 2026 04:39:23 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/ionqs-up-to-1-3-billion-elisity-deal-tests-whether-quantum-security-can-sell-now/</guid>

					<description><![CDATA[IonQ’s all-stock agreement to acquire Zero Trust specialist Elisity links a quantum platform to a current enterprise-security business. The practical question is whether that bridge creates durable customer value before quantum computing becomes a mainstream enterprise product.]]></description>
		
		
		
			</item>
		<item>
		<title>IonQ’s 1 kHz quantum-memory interconnect is a modular quantum computing milestone, not a finished network</title>
		<link>https://biztechweekly.com/ionqs-1-khz-quantum-memory-interconnect-is-a-modular-quantum-computing-milestone-not-a-finished-network/</link>
		
		<dc:creator><![CDATA[Ken Avery]]></dc:creator>
		<pubDate>Mon, 12 Oct 2026 00:18:33 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/ionqs-1-khz-quantum-memory-interconnect-is-a-modular-quantum-computing-milestone-not-a-finished-network/</guid>

					<description><![CDATA[IonQ says it generated entanglement at an average 1.03 kHz between a trapped-ion qubit and a diamond quantum memory. The result matters because it targets a key bottleneck in distributed quantum computing, while leaving the harder integration and fault-tolerance work ahead.]]></description>
		
		
		
			</item>
		<item>
		<title>NVIDIA’s $1 Billion U.S. Science Commitment Could Expand Research Capacity—and Its Platform Reach</title>
		<link>https://biztechweekly.com/nvidias-1-billion-u-s-science-commitment-could-expand-research-capacity-and-its-platform-reach/</link>
		
		<dc:creator><![CDATA[Ken Avery]]></dc:creator>
		<pubDate>Sat, 10 Oct 2026 00:18:39 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/nvidias-1-billion-u-s-science-commitment-could-expand-research-capacity-and-its-platform-reach/</guid>

					<description><![CDATA[NVIDIA says it will commit $1 billion over five years to U.S. science, tying GPUs, software, cloud access and quantum tools more tightly to universities and national labs. The practical question is whether this creates durable new research capacity or mainly makes NVIDIA’s stack harder to avoid.]]></description>
		
		
		
			</item>
		<item>
		<title>DARPA Moves Diraq Into Final Quantum Benchmarking Stage, Shifting the Debate to Manufacturing Economics</title>
		<link>https://biztechweekly.com/darpa-moves-diraq-into-final-quantum-benchmarking-stage-shifting-the-debate-to-manufacturing-economics/</link>
		
		<dc:creator><![CDATA[Michael Smith]]></dc:creator>
		<pubDate>Thu, 08 Oct 2026 12:28:56 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/darpa-moves-diraq-into-final-quantum-benchmarking-stage-shifting-the-debate-to-manufacturing-economics/</guid>

					<description><![CDATA[Diraq’s advance to Stage C of DARPA’s Quantum Benchmarking Initiative brings independent government validation—and a potential US$300 million program—to the unresolved question of whether silicon-CMOS quantum hardware can reach useful scale at an acceptable cost.]]></description>
		
		
		
			</item>
		<item>
		<title>GE HealthCare’s $945 million SOFIE deal is a bet on controlling PET’s time-critical last mile</title>
		<link>https://biztechweekly.com/ge-healthcares-945-million-sofie-deal-is-a-bet-on-controlling-pets-time-critical-last-mile/</link>
		
		<dc:creator><![CDATA[Sophia Chen]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 16:16:51 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/ge-healthcares-945-million-sofie-deal-is-a-bet-on-controlling-pets-time-critical-last-mile/</guid>

					<description><![CDATA[GE HealthCare plans to buy SOFIE Biosciences for $945 million in cash, adding 15 U.S. manufacturing sites, 21 cyclotrons and U.S. rights to Phase III tracer FAPI-74. The strategic question is whether owning a regional PET supply network improves reliability without undermining neutral access for rival drug makers.]]></description>
		
		
		
			</item>
		<item>
		<title>Vylor Starts Trading After Corteva Spinout, Putting Seed Genetics to the Standalone Test</title>
		<link>https://biztechweekly.com/vylor-starts-trading-after-corteva-spinout-putting-seed-genetics-to-the-standalone-test/</link>
		
		<dc:creator><![CDATA[Ava Davis]]></dc:creator>
		<pubDate>Fri, 02 Oct 2026 04:39:56 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/vylor-starts-trading-after-corteva-spinout-putting-seed-genetics-to-the-standalone-test/</guid>

					<description><![CDATA[Corteva has completed the 1:1 spinout of Vylor, creating a pure-play seed and genetics company on the NYSE. The immediate stock reset was mostly mechanical; the real test is whether focused ownership improves commercialization of a long-dated agricultural technology pipeline.]]></description>
		
		
		
			</item>
		<item>
		<title>AstraZeneca’s $2 Billion Summit Deal Buys Oncology Optionality, Not Proof</title>
		<link>https://biztechweekly.com/astrazenecas-2-billion-summit-deal-buys-oncology-optionality-not-proof/</link>
		
		<dc:creator><![CDATA[Ken Avery]]></dc:creator>
		<pubDate>Wed, 30 Sep 2026 12:28:49 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/astrazenecas-2-billion-summit-deal-buys-oncology-optionality-not-proof/</guid>

					<description><![CDATA[AstraZeneca is investing $2 billion in Summit Therapeutics and launching a trial collaboration around ivonescimab and Sone-Ve. The move gives AstraZeneca a strategic path into ADC combinations, but the platform thesis still depends on unproven efficacy, safety, and regulatory outcomes.]]></description>
		
		
		
			</item>
		<item>
		<title>Fervo Energy’s Cape Station Achieves First Power, Testing Whether Enhanced Geothermal Can Scale</title>
		<link>https://biztechweekly.com/fervo-energys-cape-station-achieves-first-power-testing-whether-enhanced-geothermal-can-scale/</link>
		
		<dc:creator><![CDATA[Ken Avery]]></dc:creator>
		<pubDate>Mon, 28 Sep 2026 16:17:24 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/fervo-energys-cape-station-achieves-first-power-testing-whether-enhanced-geothermal-can-scale/</guid>

					<description><![CDATA[Fervo synchronized and exported electricity from the first 33-megawatt unit at Cape Station in Utah, a milestone for enhanced geothermal systems. The practical question now is whether first power can become bankable, repeatable firm capacity across Phase I, the 400-megawatt expansion, and long-term power contracts.]]></description>
		
		
		
			</item>
		<item>
		<title>Anthropic says Claude found a novel enzyme system with CRISPR-like repeats</title>
		<link>https://biztechweekly.com/anthropic-says-claude-found-a-novel-enzyme-system-with-crispr-like-repeats/</link>
		
		<dc:creator><![CDATA[Michael Smith]]></dc:creator>
		<pubDate>Sun, 27 Sep 2026 04:39:26 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/anthropic-says-claude-found-a-novel-enzyme-system-with-crispr-like-repeats/</guid>

					<description><![CDATA[Anthropic’s first public life-sciences result suggests AI agents can materially compress genomic search and candidate triage. But the newly identified ART system still has an unknown function, leaving validation as the real test of agentic biology.]]></description>
		
		
		
			</item>
		<item>
		<title>Archer clears HSR waiting-period hurdle for Boeing’s Wisk, Insitu and SkyGrid deal</title>
		<link>https://biztechweekly.com/archer-clears-hsr-waiting-period-hurdle-for-boeings-wisk-insitu-and-skygrid-deal/</link>
		
		<dc:creator><![CDATA[Juan Martinez]]></dc:creator>
		<pubDate>Fri, 25 Sep 2026 00:18:28 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/archer-clears-hsr-waiting-period-hurdle-for-boeings-wisk-insitu-and-skygrid-deal/</guid>

					<description><![CDATA[Archer’s proposed acquisition of Boeing’s autonomy and drone subsidiaries has cleared a key antitrust waiting-period step, but the deal still needs other approvals. The practical question now is whether Archer can turn a broad aerospace-and-defense vision into an integrated, accountable business.]]></description>
		
		
		
			</item>
		<item>
		<title>TEKEVER’s $580 Million Series D Puts Europe’s Defense-Tech Scale-Up Model on Trial</title>
		<link>https://biztechweekly.com/tekevers-580-million-series-d-puts-europes-defense-tech-scale-up-model-on-trial/</link>
		
		<dc:creator><![CDATA[Ken Avery]]></dc:creator>
		<pubDate>Thu, 24 Sep 2026 12:28:23 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/tekevers-580-million-series-d-puts-europes-defense-tech-scale-up-model-on-trial/</guid>

					<description><![CDATA[TEKEVER says it has reached a first close of $580 million at a $6.4 billion valuation, days after a major UK Army drone award. The significance is less the headline valuation than whether battlefield feedback, procurement demand, and private capital can be turned into repeatable production and support.]]></description>
		
		
		
			</item>
		<item>
		<title>Meta’s MacroCycle Deal Tests Whether Environmental Credits Can Finance a U.S. Recycled-PET Plant</title>
		<link>https://biztechweekly.com/metas-macrocycle-deal-tests-whether-environmental-credits-can-finance-a-u-s-recycled-pet-plant/</link>
		
		<dc:creator><![CDATA[Sophia Chen]]></dc:creator>
		<pubDate>Wed, 23 Sep 2026 08:10:38 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/metas-macrocycle-deal-tests-whether-environmental-credits-can-finance-a-u-s-recycled-pet-plant/</guid>

					<description><![CDATA[Meta has agreed to buy environmental attribute credits tied to MacroCycle’s recycled PET output, giving the startup a potential financing bridge for its first U.S. factory before physical offtake and emissions verification are fully proven.]]></description>
		
		
		
			</item>
		<item>
		<title>Telix to Buy ITM for $1.65 Billion: Can Supply-Chain Control Outweigh ITM-11’s FDA Setback?</title>
		<link>https://biztechweekly.com/telix-to-buy-itm-for-1-65-billion-can-supply-chain-control-outweigh-itm-11s-fda-setback/</link>
		
		<dc:creator><![CDATA[Michael Smith]]></dc:creator>
		<pubDate>Wed, 23 Sep 2026 00:18:25 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/telix-to-buy-itm-for-1-65-billion-can-supply-chain-control-outweigh-itm-11s-fda-setback/</guid>

					<description><![CDATA[Telix’s planned acquisition of ITM would pair a commercial Lu-177 supplier and 65-country distribution network with Telix’s radiopharma pipeline. The strategic appeal is vertical integration; the practical test is whether Telix can resolve the manufacturing and facility issues that triggered an FDA Complete Response Letter for ITM-11.]]></description>
		
		
		
			</item>
		<item>
		<title>Laki Power’s €6 Million NATO-Backed Round Puts Self-Powered Grid Sensors to a Utility-Grade Test</title>
		<link>https://biztechweekly.com/laki-powers-e6-million-nato-backed-round-puts-self-powered-grid-sensors-to-a-utility-grade-test/</link>
		
		<dc:creator><![CDATA[Ava Davis]]></dc:creator>
		<pubDate>Sun, 20 Sep 2026 16:16:39 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/laki-powers-e6-million-nato-backed-round-puts-self-powered-grid-sensors-to-a-utility-grade-test/</guid>

					<description><![CDATA[Laki Power has raised a €6 million Series A led by the NATO Innovation Fund to scale its conductor-mounted transmission sensors. The practical question now is whether self-powered line monitoring can deliver reliable, utility-grade decisions at scale rather than just promising better visibility of remote grid assets.]]></description>
		
		
		
			</item>
		<item>
		<title>Lucid and Bolt Set a 25,000-Vehicle Europe Robotaxi Target. Here’s What Must Happen Next</title>
		<link>https://biztechweekly.com/lucid-and-bolt-set-a-25000-vehicle-europe-robotaxi-target-heres-what-must-happen-next/</link>
		
		<dc:creator><![CDATA[Ken Avery]]></dc:creator>
		<pubDate>Sat, 19 Sep 2026 00:18:36 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/lucid-and-bolt-set-a-25000-vehicle-europe-robotaxi-target-heres-what-must-happen-next/</guid>

					<description><![CDATA[Lucid and Bolt say they aim to deploy at least 25,000 fully autonomous vehicles across Europe, but the announcement matters less as a fleet count than as a checklist: type approval, named cities, production timing, remote operations, and ride economics still have to be proven.]]></description>
		
		
		
			</item>
		<item>
		<title>IBM’s Anderon Locks In a $1 Billion CHIPS Award. Now the Quantum Foundry Test Begins.</title>
		<link>https://biztechweekly.com/ibms-anderon-locks-in-a-1-billion-chips-award-now-the-quantum-foundry-test-begins/</link>
		
		<dc:creator><![CDATA[Juan Martinez]]></dc:creator>
		<pubDate>Thu, 17 Sep 2026 16:16:56 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/ibms-anderon-locks-in-a-1-billion-chips-award-now-the-quantum-foundry-test-begins/</guid>

					<description><![CDATA[Anderon, an IBM company, finalized a $1 billion CHIPS award alongside IBM’s separate $1 billion commitment for quantum-wafer R&#038;D in Albany. The practical question is whether that funding translates into measurable yield, reproducibility, and outside-customer access—not just a bigger strategic bet.]]></description>
		
		
		
			</item>
		<item>
		<title>BioVie ADDRESS-LC topline results: Bezisterim shows a Long COVID subgroup signal, but misses overall significance</title>
		<link>https://biztechweekly.com/biovie-address-lc-topline-results-bezisterim-shows-a-long-covid-subgroup-signal-but-misses-overall-significance/</link>
		
		<dc:creator><![CDATA[Aarav Patel]]></dc:creator>
		<pubDate>Wed, 16 Sep 2026 07:46:19 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/biovie-address-lc-topline-results-bezisterim-shows-a-long-covid-subgroup-signal-but-misses-overall-significance/</guid>

					<description><![CDATA[BioVie reported no statistically significant endpoint in the full 203-patient Phase 2 ADDRESS-LC population, while pre-specified higher-burden subgroups showed coherent gains. The practical question now is whether those exploratory signals are strong enough to anchor a credible Phase 3 design.]]></description>
		
		
		
			</item>
		<item>
		<title>NASA Field-Tests Three-Robot ASTRA AI Fleet, but Trustworthy Autonomy Still Needs Proof</title>
		<link>https://biztechweekly.com/nasa-field-tests-three-robot-astra-ai-fleet-but-trustworthy-autonomy-still-needs-proof/</link>
		
		<dc:creator><![CDATA[Sophia Chen]]></dc:creator>
		<pubDate>Wed, 16 Sep 2026 07:36:55 +0000</pubDate>
				<category><![CDATA[Emerging Tech]]></category>
		<guid isPermaLink="false">https://biztechweekly.com/nasa-field-tests-three-robot-astra-ai-fleet-but-trustworthy-autonomy-still-needs-proof/</guid>

					<description><![CDATA[NASA’s summer 2026 ASTRA field test showed a drone and two rovers could reprioritize work around a new scientific lead without dropping the original task. The result is a meaningful autonomy milestone, but the operational case still depends on repeatability, degraded-mode behavior, and human-override evidence NASA has not yet published.]]></description>
		
		
		
			</item>
	</channel>
</rss>
